China's Regulatory Scrutiny And Market Shifts Will Undermine Value
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
10 May 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$8.10
38.4% overvalued intrinsic discount16 Aug
US$11.21
1Y
43.7%7D
11.0%